aluates Reports

$ 0.0

Automative

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-15123

Global Single Nucleotide Polymorphism SNP Genotyping Market Size Status and Forecast 2022

BUY CHAPTERS

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2024

Code: QYRE-Auto-15123

Report

January 2024

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Illumina Inc

Affymetrix Inc

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen NV

Luminex Corporation

Enzo Life Sciences

Bio Rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

Single Nucleotide Polymorphism (SNP) Genotyping Market Size

The global Single Nucleotide Polymorphism (SNP) Genotyping market was valued at US$ 16900 million in 2023 and is anticipated to reach US$ 65510 million by 2030, witnessing a CAGR of 21.1% during the forecast period 2024-2030.

Single Nucleotide Polymorphism (SNP) Genotyping Market

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.

North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.

In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

This report aims to provide a comprehensive presentation of the global market for Single Nucleotide Polymorphism (SNP) Genotyping, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Nucleotide Polymorphism (SNP) Genotyping.

Report Scope

The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single Nucleotide Polymorphism (SNP) Genotyping market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Single Nucleotide Polymorphism (SNP) Genotyping companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Single Nucleotide Polymorphism (SNP) Genotyping Market Report

Report Metric	Details
Report Name	Single Nucleotide Polymorphism (SNP) Genotyping Market
Accounted market size in 2023	US$ 16900 million
Forecasted market size in 2030	US$ 65510 million
CAGR	21.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Transversion Transition
Segment by Application	Diagnostics Animal Plant Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation, Enzo Life Sciences, Bio-rad, Sequenom, Ocimum Biosolutions, GE Healthcare, GenScript, Douglas Scientific, BGI, Beijing Sunbiotech, HuaGene Biotech, Generay Biotech, Benegene, Shanghai Biochip, GENESKY, HD Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Single Nucleotide Polymorphism (SNP) Genotyping Market growing?

Ans: The Single Nucleotide Polymorphism (SNP) Genotyping Market witnessing a CAGR of 21.1% during the forecast period 2024-2030.

What is the Single Nucleotide Polymorphism (SNP) Genotyping Market size in 2030?

Ans: The Single Nucleotide Polymorphism (SNP) Genotyping Market size in 2030 will be US$ 65510 million.

What is the market share of major companies in Single Nucleotide Polymorphism (SNP) Genotyping Market?

Ans: Global top five players hold a share about 65%.

Who are the main players in the Single Nucleotide Polymorphism (SNP) Genotyping Market report?

Ans: The main players in the Single Nucleotide Polymorphism (SNP) Genotyping Market are Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation, Enzo Life Sciences, Bio-rad, Sequenom, Ocimum Biosolutions, GE Healthcare, GenScript, Douglas Scientific, BGI, Beijing Sunbiotech, HuaGene Biotech, Generay Biotech, Benegene, Shanghai Biochip, GENESKY, HD Biosciences

What are the Application segmentation covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report?

Ans: The Applications covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report are Diagnostics, Animal, Plant, Research, Others

What are the Type segmentation covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report?

Ans: The Types covered in the Single Nucleotide Polymorphism (SNP) Genotyping Market report are Transversion, Transition

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Transversion

1.2.3 Transition

1.3 Market by Application

1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Diagnostics

1.3.3 Animal

1.3.4 Plant

1.3.5 Research

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2019-2030)

2.2 Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Region

2.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Region (2019-2024)

2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2025-2030)

2.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics

2.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends

2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers

2.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges

2.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue

3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2019-2024)

3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2019-2024)

3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue

3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio

3.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2023

3.5 Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Area Served

3.6 Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service

3.7 Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Type

4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2019-2024)

4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2025-2030)

5 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Application

5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2019-2024)

5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2019-2030)

6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024)

6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2019-2030)

7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024)

7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2019-2030)

8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2019-2024)

8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2019-2030)

9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024)

9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2019-2030)

10.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024)

10.4 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Detail

11.1.2 Illumina Business Overview

11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.1.5 Illumina Recent Development

11.2 Affymetrix

11.2.1 Affymetrix Company Detail

11.2.2 Affymetrix Business Overview

11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.2.5 Affymetrix Recent Development

11.3 Applied Biosystems

11.3.1 Applied Biosystems Company Detail

11.3.2 Applied Biosystems Business Overview

11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.3.5 Applied Biosystems Recent Development

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Detail

11.4.2 Agilent Technologies Business Overview

11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.4.5 Agilent Technologies Recent Development

11.5 Beckman Coulter

11.5.1 Beckman Coulter Company Detail

11.5.2 Beckman Coulter Business Overview

11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.5.5 Beckman Coulter Recent Development

11.6 Roche

11.6.1 Roche Company Detail

11.6.2 Roche Business Overview

11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.6.5 Roche Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Detail

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.7.5 Qiagen Recent Development

11.8 Luminex Corporation

11.8.1 Luminex Corporation Company Detail

11.8.2 Luminex Corporation Business Overview

11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.8.5 Luminex Corporation Recent Development

11.9 Enzo Life Sciences

11.9.1 Enzo Life Sciences Company Detail

11.9.2 Enzo Life Sciences Business Overview

11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.9.5 Enzo Life Sciences Recent Development

11.10 Bio-rad

11.10.1 Bio-rad Company Detail

11.10.2 Bio-rad Business Overview

11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.10.5 Bio-rad Recent Development

11.11 Sequenom

11.11.1 Sequenom Company Detail

11.11.2 Sequenom Business Overview

11.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.11.5 Sequenom Recent Development

11.12 Ocimum Biosolutions

11.12.1 Ocimum Biosolutions Company Detail

11.12.2 Ocimum Biosolutions Business Overview

11.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.12.5 Ocimum Biosolutions Recent Development

11.13 GE Healthcare

11.13.1 GE Healthcare Company Detail

11.13.2 GE Healthcare Business Overview

11.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.13.5 GE Healthcare Recent Development

11.14 GenScript

11.14.1 GenScript Company Detail

11.14.2 GenScript Business Overview

11.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.14.5 GenScript Recent Development

11.15 Douglas Scientific

11.15.1 Douglas Scientific Company Detail

11.15.2 Douglas Scientific Business Overview

11.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.15.5 Douglas Scientific Recent Development

11.16 BGI

11.16.1 BGI Company Detail

11.16.2 BGI Business Overview

11.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.16.5 BGI Recent Development

11.17 Beijing Sunbiotech

11.17.1 Beijing Sunbiotech Company Detail

11.17.2 Beijing Sunbiotech Business Overview

11.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.17.5 Beijing Sunbiotech Recent Development

11.18 HuaGene Biotech

11.18.1 HuaGene Biotech Company Detail

11.18.2 HuaGene Biotech Business Overview

11.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.18.5 HuaGene Biotech Recent Development

11.19 Generay Biotech

11.19.1 Generay Biotech Company Detail

11.19.2 Generay Biotech Business Overview

11.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.19.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.19.5 Generay Biotech Recent Development

11.20 Benegene

11.20.1 Benegene Company Detail

11.20.2 Benegene Business Overview

11.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.20.5 Benegene Recent Development

11.21 Shanghai Biochip

11.21.1 Shanghai Biochip Company Detail

11.21.2 Shanghai Biochip Business Overview

11.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.21.5 Shanghai Biochip Recent Development

11.22 GENESKY

11.22.1 GENESKY Company Detail

11.22.2 GENESKY Business Overview

11.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.22.5 GENESKY Recent Development

11.23 HD Biosciences

11.23.1 HD Biosciences Company Detail

11.23.2 HD Biosciences Business Overview

11.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction

11.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

11.23.5 HD Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Illumina Inc

Affymetrix Inc

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen NV

Luminex Corporation

Enzo Life Sciences

Bio Rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

List of Tables

Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Transversion

Table 3. Key Players of Transition

Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2019-2024)

Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2025-2030)

Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends

Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers

Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges

Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints

Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2019-2024)

Table 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2023)

Table 17. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service

Table 21. Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2019-2024)

Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2025-2030)

Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2019-2024)

Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2025-2030)

Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2025-2030) & (US$ Million)

Table 46. Illumina Company Detail

Table 47. Illumina Business Overview

Table 48. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 49. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 50. Illumina Recent Development

Table 51. Affymetrix Company Detail

Table 52. Affymetrix Business Overview

Table 53. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 54. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 55. Affymetrix Recent Development

Table 56. Applied Biosystems Company Detail

Table 57. Applied Biosystems Business Overview

Table 58. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 59. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 60. Applied Biosystems Recent Development

Table 61. Agilent Technologies Company Detail

Table 62. Agilent Technologies Business Overview

Table 63. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 64. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 65. Agilent Technologies Recent Development

Table 66. Beckman Coulter Company Detail

Table 67. Beckman Coulter Business Overview

Table 68. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 69. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 70. Beckman Coulter Recent Development

Table 71. Roche Company Detail

Table 72. Roche Business Overview

Table 73. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 74. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 75. Roche Recent Development

Table 76. Qiagen Company Detail

Table 77. Qiagen Business Overview

Table 78. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 79. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 80. Qiagen Recent Development

Table 81. Luminex Corporation Company Detail

Table 82. Luminex Corporation Business Overview

Table 83. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 84. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 85. Luminex Corporation Recent Development

Table 86. Enzo Life Sciences Company Detail

Table 87. Enzo Life Sciences Business Overview

Table 88. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 89. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 90. Enzo Life Sciences Recent Development

Table 91. Bio-rad Company Detail

Table 92. Bio-rad Business Overview

Table 93. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 94. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 95. Bio-rad Recent Development

Table 96. Sequenom Company Detail

Table 97. Sequenom Business Overview

Table 98. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 99. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 100. Sequenom Recent Development

Table 101. Ocimum Biosolutions Company Detail

Table 102. Ocimum Biosolutions Business Overview

Table 103. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 104. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 105. Ocimum Biosolutions Recent Development

Table 106. GE Healthcare Company Detail

Table 107. GE Healthcare Business Overview

Table 108. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 109. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 110. GE Healthcare Recent Development

Table 111. GenScript Company Detail

Table 112. GenScript Business Overview

Table 113. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 114. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 115. GenScript Recent Development

Table 116. Douglas Scientific Company Detail

Table 117. Douglas Scientific Business Overview

Table 118. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 119. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 120. Douglas Scientific Recent Development

Table 121. BGI Company Detail

Table 122. BGI Business Overview

Table 123. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 124. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 125. BGI Recent Development

Table 126. Beijing Sunbiotech Company Detail

Table 127. Beijing Sunbiotech Business Overview

Table 128. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 129. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 130. Beijing Sunbiotech Recent Development

Table 131. HuaGene Biotech Company Detail

Table 132. HuaGene Biotech Business Overview

Table 133. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 134. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 135. HuaGene Biotech Recent Development

Table 136. Generay Biotech Company Detail

Table 137. Generay Biotech Business Overview

Table 138. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 139. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 140. Generay Biotech Recent Development

Table 141. Benegene Company Detail

Table 142. Benegene Business Overview

Table 143. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 144. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 145. Benegene Recent Development

Table 146. Shanghai Biochip Company Detail

Table 147. Shanghai Biochip Business Overview

Table 148. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 149. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 150. Shanghai Biochip Recent Development

Table 151. GENESKY Company Detail

Table 152. GENESKY Business Overview

Table 153. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 154. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 155. GENESKY Recent Development

Table 156. HD Biosciences Company Detail

Table 157. HD Biosciences Business Overview

Table 158. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product

Table 159. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024) & (US$ Million)

Table 160. HD Biosciences Recent Development

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2023 VS 2030

Figure 3. Transversion Features

Figure 4. Transition Features

Figure 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2023 VS 2030

Figure 7. Diagnostics Case Studies

Figure 8. Animal Case Studies

Figure 9. Plant Case Studies

Figure 10. Research Case Studies

Figure 11. Others Case Studies

Figure 12. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered

Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2023 VS 2030

Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2023

Figure 17. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2023

Figure 19. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2019-2030)

Figure 21. United States Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2019-2030)

Figure 25. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2019-2030)

Figure 33. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2019-2030)

Figure 41. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2019-2030)

Figure 45. Turkey Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 48. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 49. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 50. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 51. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 52. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 53. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 54. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 55. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 56. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 57. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 58. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 59. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 60. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 61. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 62. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 63. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 64. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 65. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 66. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 67. Shanghai Biochip Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 68. GENESKY Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 69. HD Biosciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RNA and DNA Extraction Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36Z8348

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global DNA Library Preparation Kits Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-5U6259

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Edible Insects Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20A9325

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global DNA Repair Proteins And Reagents Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9S9524

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions